Friday Flashback for May 1, 2009
It’s Friday, I’m on vacation, so you might as well enjoy these oldies but goodies from years gone by.
10 Years Ago on Psych Central
Becoming Stuck Online
Ten years ago, I was contemplating my first big career move, leaving a company I had been with for four years in Columbus, Ohio and moving to Austin, Texas to go to work for an Internet startup called drkoop.com. No wonder I was feeling “stuck,” as the job I had created for myself was no longer very challenging (especially with the limited resources I had available versus the rampant resources available to startups).
5 Years Ago on Psych Central
J&J Warned on Claims About Antipsychotic Drug
In an ominous warning of things to come, the U.S. Food and Drug Administration (FDA) 5 years ago warned the J&J unit Janssen Pharmaceutica that some of the marketing materials it was sending to doctors about its antipsychotic Risperdal failed to mention the serious side effects like excess blood sugar and diabetes, and minimized the risk of serious events including coma and even death. That didn’t stop the FDA from approving Risperdal 3 years later for the treatment of schizophrenia in adolescents ages 13-17 and for the short-term treatment of bipolar mania associated with manic or mixed episodes of bipolar I disorder in children and adolescents ages 10-17.
If Not Pills, What?
The practice guidelines of the American Academy of Child and Adolescent Psychiatrists (AACAP) hold that talk therapy (also known as psychotherapy) should be the first line of treatment for children with depression. Medication is called for as a first treatment only in the most severe cases of depression — when a child is incapacitated, suicidal or otherwise endangered by the illness.
1 Year Ago on Psych Central
I Think I’m in Love with My Therapist
One of our more popular blog entries, we explored those feelings one might experience in psychotherapy that seem very much like being in love with your therapist. Often something called “transference,” such feelings are actually more common than you might think and a perfectly normal and health part of therapy.
Need to Get Into College? Try ADHD!
We noted a newspaper advice column that complained of parents who have their children tested and diagnosed with attention deficit disorders so the students have the advantage of prescription medicine and untimed standardized tests. Not sure if that’s a good idea since such labels may follow a teen far into their adult lives (and careers), especially if they don’t actually have ADHD. See also our most recent entry on ADHD and college, Dealing with ADHD while away at college.
When a Generic Isn’t Equal to the Brand Name
Like most people, I’ve always taken for granted that because the FDA says it’s true, it must be. So generic medications must be just as good as their name-brand counterparts. That is, until I read about people’s experiences with the generic form of Wellbutrin XL — bupropion XL — in 2006. Joe and Terry Graedon of The People’s Pharmacy conducted their own investigation into the bioequivalence of it and found it, well, not exactly the same as the name brand. A year later, nothing’s changed as far as I can tell. The FDA hasn’t changed their generic standards, and we seem still to be stuck with sometimes-inferior medications masquerading as the real thing.
Grohol, J. (2009). Friday Flashback for May 1, 2009. Psych Central. Retrieved on January 17, 2017, from http://psychcentral.com/blog/archives/2009/05/01/friday-flashback-for-may-1-2009/